hello, new to (as) question is if steroids promote recovery / strength, then igf promotes size/growth?
why is evryone more interested in talking about raising test levels as apposed to IGF # ?
my test # is 2376 and my igf IS 347 AT 36YO, I am in the high range. so where should i be? to inhibate muscle growth to full potential?
SOMATOMEDIN-C
347
SEE BELOW
NG/ML
******* EXPECTED VALUES FOR SOMATOMEDIN-C ******
REFERENCE RANGE BY AGE:
1-8 YEARS . . . . . . . . . . . . . NG/ML 50-345
9-11 YEARS . . . . . . . . . . . . . NG/ML 74-551
12-15 YEARS . . . . . . . . . . . . . NG/ML 143-966
16-20 YEARS . . . . . . . . . . . . . NG/ML 127-903
21-30 YEARS . . . . . . . . . . . . . NG/ML 116-358
31-40 YEARS . . . . . . . . . . . . . NG/ML 109-307
41-55 YEARS . . . . . . . . . . . . . NG/ML 87-267
>/=56 YEARS . . . . . . . . . . . . . NG/ML 55-225
VALUES BY TANNER STAGE:
STAGE UNITS MALE FEMALE
I . . . . . . . . . . . . . NG/ML 49-342 63-279
II . . . . . . . . . . . . . NG/ML 115-428 75-420
III . . . . . . . . . . . . . NG/ML 145-760 94-765
IV . . . . . . . . . . . . . NG/ML 244-787 192-861
V . . . . . . . . . . . . . NG/ML 143-859 171-814
why is evryone more interested in talking about raising test levels as apposed to IGF # ?
my test # is 2376 and my igf IS 347 AT 36YO, I am in the high range. so where should i be? to inhibate muscle growth to full potential?
SOMATOMEDIN-C
347
SEE BELOW
NG/ML
******* EXPECTED VALUES FOR SOMATOMEDIN-C ******
REFERENCE RANGE BY AGE:
1-8 YEARS . . . . . . . . . . . . . NG/ML 50-345
9-11 YEARS . . . . . . . . . . . . . NG/ML 74-551
12-15 YEARS . . . . . . . . . . . . . NG/ML 143-966
16-20 YEARS . . . . . . . . . . . . . NG/ML 127-903
21-30 YEARS . . . . . . . . . . . . . NG/ML 116-358
31-40 YEARS . . . . . . . . . . . . . NG/ML 109-307
41-55 YEARS . . . . . . . . . . . . . NG/ML 87-267
>/=56 YEARS . . . . . . . . . . . . . NG/ML 55-225
VALUES BY TANNER STAGE:
STAGE UNITS MALE FEMALE
I . . . . . . . . . . . . . NG/ML 49-342 63-279
II . . . . . . . . . . . . . NG/ML 115-428 75-420
III . . . . . . . . . . . . . NG/ML 145-760 94-765
IV . . . . . . . . . . . . . NG/ML 244-787 192-861
V . . . . . . . . . . . . . NG/ML 143-859 171-814
Comment